Shelly Lanning

Redesigning women's health | Investor | Operator

📍 United States🔄 Updated September 2026💼 3 investments📅 19 years investing🗓 Last invested Jun 2021
VC🌍 United States
3
Total investments
1
Early stage
1
Mid stage
0
Late stage
19y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor | Board Member
Jun 2021
FlyteHealth is a tech-enabled healthcare services organization born of the belief that everyone deserves to live a healthy life. Our efforts to bring the most effective health care to people with obesity, while making it cost-efficient to do so, mean that more people can transform their health for the better—now and for the rest of their lives. We were founded by physicians who were the first to recognize obesity not as a simple issue of willpower, but as a complex disease that requires expert medical treatment. Based on their decades of research and caring for patients, our clinically proven approach combines the latest in personalized medication therapy and behavior coaching that not only helps people lose weight for the long term, but significantly improves related conditions. Our obesity treatment platform, powered by Flyte Intelligence, is built from the largest data set of obesity and chronic disease research available, empowering healthcare providers—our own FlyteHealth clinicians and those of our healthcare partners—to deliver the highest standards of care, consistently. While others are jumping on the GLP-1 bandwagon, we see a better way. One that allows employers and payers to offer the best in obesity care, while keeping costs under control. FlyteHealth clinicians prescribe GLP-1 medications strategically, alongside lower-cost generics, for treatment that’s specific to what our patients’ bodies truly need and delivers better control over health care costs. Obesity care goes well beyond weight loss. FlyteHealth gives patients the power to achieve a lifetime of better health. Whether they are actively losing weight or maintaining a normal BMI, we deliver clinical care and coordinate with care teams to help them manage optimal health for life. At FlyteHealth, we’re committed to making sure nothing stands in the way of someone getting the care they need. Together, we’re a collective force for fighting chronic disease.
Investor | Board Member
2017
GHOST is the world’s first lifestyle sports nutrition brand. GHOST encourages people to rethink the boundaries and lifestyles championed by traditional sports nutrition brands in exchange for an all encompassing, fit-lifestyle. GHOST products can be found online at ghostlifestyle.com and in-store at GNC and select retailers worldwide.
Experience · 7 entries
All (7)
Investments (3)
Founder (1)
Board (3)
2022
Co-Founder | President
Feb 2022
Visana Health is the worlds most comprehensive virtual womens health clinic, providing medical care and integrated whole-person support for every phase of a womans life. While other womens health companies focus on fertility and maternity, Visana is the only company focused on providing longitudinal, value-based care from menstruation to menopause, including preventive care, urgent care, and complex gynecology care. To learn more, visit www.visanahealth.com.
2021
Investor | Board Member
Jun 2021
FlyteHealth is a tech-enabled healthcare services organization born of the belief that everyone deserves to live a healthy life. Our efforts to bring the most effective health care to people with obesity, while making it cost-efficient to do so, mean that more people can transform their health for the better—now and for the rest of their lives. We were founded by physicians who were the first to recognize obesity not as a simple issue of willpower, but as a complex disease that requires expert medical treatment. Based on their decades of research and caring for patients, our clinically proven approach combines the latest in personalized medication therapy and behavior coaching that not only helps people lose weight for the long term, but significantly improves related conditions. Our obesity treatment platform, powered by Flyte Intelligence, is built from the largest data set of obesity and chronic disease research available, empowering healthcare providers—our own FlyteHealth clinicians and those of our healthcare partners—to deliver the highest standards of care, consistently. While others are jumping on the GLP-1 bandwagon, we see a better way. One that allows employers and payers to offer the best in obesity care, while keeping costs under control. FlyteHealth clinicians prescribe GLP-1 medications strategically, alongside lower-cost generics, for treatment that’s specific to what our patients’ bodies truly need and delivers better control over health care costs. Obesity care goes well beyond weight loss. FlyteHealth gives patients the power to achieve a lifetime of better health. Whether they are actively losing weight or maintaining a normal BMI, we deliver clinical care and coordinate with care teams to help them manage optimal health for life. At FlyteHealth, we’re committed to making sure nothing stands in the way of someone getting the care they need. Together, we’re a collective force for fighting chronic disease.
2017
Investor | Board Member
2017
GHOST is the world’s first lifestyle sports nutrition brand. GHOST encourages people to rethink the boundaries and lifestyles championed by traditional sports nutrition brands in exchange for an all encompassing, fit-lifestyle. GHOST products can be found online at ghostlifestyle.com and in-store at GNC and select retailers worldwide.
2007
Galil Medical, a BTG International group company
Board Member
Mar 2007
Managing Director, HealthCor Venture Partners
2007
HealthCor Management, L.P. (“HealthCor”) launched on September 1, 2005 and is based in New York. HealthCor is an investment management firm focused principally on the global healthcare and life sciences industry. HealthCor is one of the largest healthcare sector focused firms with an investment team that includes 2 Portfolio Managers, Joseph Healey and Arthur Cohen. The Portfolio Managers have over 15 years of co-investing in healthcare together, over 40 combined years of managing healthcare portfolios and over 50 combined years of being on the buy-side. HealthCor’s investment objective is to achieve superior risk-adjusted returns primarily through investments in equity and equity-related instruments where it uses a fundamental bottom up research driven approach to stock selection across the major sub-sectors of healthcare and life sciences including pharmaceuticals, medtech, biotech and services. As of January 3, 2023, the team and therapeutics strategy of HealthCor Management, L.P. was acquired by Catalio Capital Management, LP.
Show all 7 entries ↓
Investment activity
2007–2021 · 3 investments
200712017120211
Recent (last 2 years)Earlier